CDISC EUROPE FOUNDATION FONDATION

Their core work

CDISC Europe Foundation is the European arm of the Clinical Data Interchange Standards Consortium, a global nonprofit that develops and maintains data standards (SDTM, CDASH, ADaM, ODM) used in clinical research and regulatory submissions worldwide. In EU research consortia, they contribute deep expertise in clinical data interoperability — ensuring that patient data generated across different healthcare systems and clinical trials can be exchanged, reused, and understood consistently. Their participation in H2020 projects spans EU/US cross-border patient data harmonization and AI-driven clinical decision support, where standardized data is the prerequisite for reliable AI performance. They act as the bridge between research-stage health data and real-world regulatory and clinical deployment requirements.

What they specialise in

How they've shifted over time

In their early H2020 work (Trillium II, 2017–2019), CDISC focused on foundational data exchange: harmonizing patient summary standards between EU and US health systems, a classic standards-body role with no AI component. By 2020, with DRAGON, their project context shifted substantially toward AI-enhanced diagnostics, deep learning, and pandemic-responsive clinical tools — suggesting that demand for their data standards expertise now comes increasingly from AI and precision medicine consortia that need machine-readable, interoperable datasets as a precondition. The trend is clear: CDISC remains a standards specialist, but the application layer around them has moved from policy-driven interoperability to AI-driven clinical intelligence.

CDISC is being drawn into AI and precision medicine consortia where standardized, regulatory-grade data is the bottleneck — making them increasingly relevant as clinical AI projects scale up.

How they like to work

CDISC has never led an H2020 project, participating exclusively as a consortium partner — consistent with a standards organization that contributes specialist knowledge rather than managing research programs. Their 37 unique partners across just 2 projects points to large, multi-institutional consortia (roughly 18–19 partners per project), typical of health RIA and CSA calls. This profile suggests they are specifically recruited for their standards expertise and are not a general-purpose research executor.

With 37 unique consortium partners across 15 countries in only 2 projects, CDISC operates in large, internationally diverse health research networks. Their Trillium II involvement in EU/US cooperation suggests their network extends beyond Europe into North America, giving them an unusually broad geographic reach for a Brussels-based SME.

What sets them apart

CDISC Europe Foundation occupies a rare position in health research consortia: they are one of the few EU-registered organizations with direct institutional ties to globally mandated clinical data standards recognized by both the EMA and the FDA. For any health project whose outputs need to be deployable in real clinical or regulatory contexts — not just published as research — CDISC provides the standards credibility that peer institutions cannot. Consortia building AI diagnostics, precision medicine tools, or cross-border health data infrastructure gain direct access to the organization that writes the rules those tools must comply with.

Highlights from their portfolio

• DRAGON
  The largest funded project (EUR 485,345), combining AI, deep learning, pandemic management, and precision medicine — representing CDISC's most applied and technically ambitious H2020 engagement.
• Trillium II
  One of the few H2020 projects explicitly focused on EU/US health data cooperation, placing CDISC at the center of transatlantic clinical standards harmonization.